1 Cash-Producing Stock to Consider Right Now and 2 Facing Challenges
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Luckily for you, we built StockStory to help you separate the good from the bad. Keeping that in mind, here is one cash-producing company that reinvests wisely to drive long-term success and two that may face some trouble.
Two Stocks to Sell:
America's Car-Mart (CRMT)
Trailing 12-Month Free Cash Flow Margin: 5%
With a strong presence in the Southern and Central US, America’s Car-Mart (NASDAQ:CRMT) sells used cars to budget-conscious consumers.
Why Should You Sell CRMT?
- Disappointing same-store sales over the past two years show customers aren’t responding well to its product selection and store experience
- Issuance of new shares over the last three years caused its earnings per share to fall by 41.5% annually, even worse than its revenue declines
- Unprofitable operations could lead to additional rounds of dilutive equity financing if the credit window closes
America's Car-Mart is trading at $3.08 per share, or 27.2x forward EV-to-EBITDA. To fully understand why you should be careful with CRMT, check out our full research report (it’s free).
AdaptHealth (AHCO)
Trailing 12-Month Free Cash Flow Margin: 3.2%
With a network of approximately 680 locations serving patients across all 50 states, AdaptHealth (NASDAQ:AHCO) provides home medical equipment, supplies, and related services to patients with chronic conditions like sleep apnea, diabetes, and respiratory disorders.
Why Do We Steer Clear of AHCO?
- Annual sales declines of 2.7% for the past two years show its products and services struggled to connect with the market during this cycle
- Earnings per share have dipped by 20.7% annually over the past five years, which is concerning because stock prices follow EPS over the long term
- Low returns on capital reflect management’s struggle to allocate funds effectively, and its shrinking returns suggest its past profit sources are losing steam
AdaptHealth’s stock price of $5.73 implies a valuation ratio of 5.4x forward EV-to-EBITDA. If you’re considering AHCO for your portfolio, see our FREE research report to learn more.
One Stock to Watch:
Allegion (ALLE)
Trailing 12-Month Free Cash Flow Margin: 15.6%
Allegion plc (NYSE:ALLE) is a provider of security products and solutions that keep people and assets safe and secure in various environments.
Why Are We Positive on ALLE?
- Highly efficient business model is illustrated by its impressive 19.8% operating margin, and its profits increased over the last five years as it scaled
- Free cash flow margin jumped by 6.1 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
- Industry-leading 21.9% return on capital demonstrates management’s skill in finding high-return investments
At $166.37 per share, Allegion trades at 17.7x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.